Physician profile
Thomas A Duncan
NPI 1386082790
$900.36
in general payments reported to CMS, 2019-2025
21 companies · $64.07 in 2025
The $64.07 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $161 · 2021: $118 · 2022: $112 · 2023: $150 · 2024: $104 · 2025: $64.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.63 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $171.66 | 2019-2024 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $87.78 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $85.24 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.22 | 2019-2025 | |
| Pfizer INC. | $38.48 | 2019-2022 | |
| Ethicon US, LLC | $35.98 | 2019 | |
| Organon LLC | $30.36 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $26.49 | 2021 | |
| Daiichi Sankyo INC. | $25.26 | 2024 | Injectafer |
| Vertex Pharmaceuticals Incorporated | $22.99 | 2024 | |
| Roche Diagnostics Corporation | $19.49 | 2019 | |
| Meditrina | $19.17 | 2023 | |
| Ironshore Pharmaceuticals INC. | $18.89 | 2020 | |
| Si-Bone, INC. | $18.28 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.06 | 2019 | |
| Astellas Pharma Global Development | $16.66 | 2025 | Veozah |
| Smith+Nephew, INC. | $14.56 | 2020 | |
| Minerva Surgical, INC | $12.82 | 2023 | |
| Boston Scientific Corporation | $12.03 | 2019 | |
| Intuitive Surgical, INC. | $4.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.